Lucid Diagnostics (LUCD) Receivables (2021 - 2026)
Lucid Diagnostics (LUCD) posted Receivables of $689000.0 for Q1 2026, up 7.15% on a QoQ basis from $643000.0 in Q4 2025, and up 1029.51% year-over-year from $61000.0 in Q1 2025.
Lucid Diagnostics (LUCD) Receivables (2021 - 2026) Analysis & Trends
Lucid Diagnostics' Receivables history runs 6 years deep, the most recent figure standing at $689000.0 for Q1 2026.
- Quarterly Receivables rose 1029.51% year-over-year to $689000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $689000.0 (up 1029.51% YoY) and the FY2025 annual result came in at $643000.0, up 1328.89% from the prior year.
- Receivables was $689000.0 for Q1 2026 at Lucid Diagnostics, up from $643000.0 in the prior quarter.
- Across five years, Receivables topped out at $10.7 million in Q2 2023 and bottomed at $21000.0 in Q3 2023.
- A 5-year average of $2.2 million and a median of $461500.0 in 2025 frame the typical range for Receivables.
- Annual changes were most pronounced in 2022 — Receivables surged 3220.5% — and 2023, when it slumped 99.68%.
- Lucid Diagnostics' Receivables stood at $5.0 million in 2022, then sank by 99.1% to $45000.0 in 2023, then changed by 0.0% to $45000.0 in 2024, then soared by 1328.89% to $643000.0 in 2025, then rose by 7.15% to $689000.0 in 2026.
- Business Quant data shows LUCD's Receivables at $689000.0 in Q1 2026, $643000.0 in Q4 2025, and $550000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 8.21 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 3.57 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.64 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 3.03 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 973.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 1.11 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 3.80 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 4.50 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.55 Bn |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | 689,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 689,000.00 |
| Dec 31, 2025 | 643,000.00 |
| Sep 30, 2025 | 550,000.00 |
| Jun 30, 2025 | 373,000.00 |
| Mar 31, 2025 | 61,000.00 |
| Dec 31, 2024 | 45,000.00 |
| Sep 30, 2024 | 39,000.00 |
| Jun 30, 2024 | 160,000.00 |
| Mar 31, 2024 | 49,000.00 |
| Dec 31, 2023 | 45,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Jun 30, 2023 | 10.73 Mn |
| Mar 31, 2023 | 7.65 Mn |
| Dec 31, 2022 | 4.98 Mn |
| Sep 30, 2022 | 6.64 Mn |
| Mar 31, 2022 | 1.86 Mn |
| Dec 31, 2021 | 1.86 Mn |
| Sep 30, 2021 | 200,000.00 |